BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2020
View Archived Issues
GNOS-PV02 vaccine to be evaluated in patients with HCC
Read More
AI-generated compound begins phase I study in Japan for obsessive-compulsive disorder
Read More
Inovio and Beijing Advaccine collaborate to advance new vaccine against new coronavirus in China
Read More
BREEZE-AD5 phase II study of baricitinib in AD meets primary endpoint
Read More
German Medicines Agency approves phase II study of FOL-005
Read More
Kedrion Biopharma completes enrollment in phase III CARES10 study
Read More
Cerevel starts dosing volunteers in phase I study of CVL-936
Read More
First patient dosed in phase Ib study of GMI-1359 in breast cancer
Read More
FDA accepts IND application for FS-120 bispecific antibody
Read More
BBI-608 plus pembrolizumab shows encouraging antitumor activity in mCRC
Read More
Magrolimab plus cetuximab as a promising immunotherapeutic treatment regimen in CRC
Read More
Phase II study of PBI-05204 in mPDA does not meet primary endpoint
Read More
Fimbrion Therapeutics and GlaxoSmithKline describe Escherichia coli FimH inhibitors
Read More
New high affinity nerve growth factor receptor inhibitors identified at Medshine Discovery
Read More
Naltrexone prodrugs synthesized at Alkermes
Read More
Novartis patents compounds for IKZF2-dependent disease
Read More
Recordati Industria Chimica e Farmaceutica discovers P2X3 and P2X2/3 antagonists
Read More
"Confused and disorganized": Stress, identity crises part of growing up -- for organoids
Read More
RC-48-ADC shows meaningful benefit in phase I solid tumors trial
Read More
CEACAM6 levels linked to sensitivity to pelareorep in pancreatic adenocarcinoma
Read More
IRICoR, UdeM and Medigene establish collaboration on novel cancer antigens
Read More
Phase I study of Rani's orally delivered octreotide meets primary and secondary endpoints
Read More
Fuzionaire Diagnostics establishes new research collaboration in neurodegeneration
Read More
IND clearance for VistaGen's AV-101 for levodopa-induced dyskinesia in Parkinson's
Read More
Immune Response BioPharma plans IND filing for new SARS/coronavirus vaccine
Read More
